Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma

Huiying Xue, Yong Liu, Jiazhi Liao, Jusheng Lin, Bin Li, Weigang Yuan, Robert J. Lee, Lei Li, Chuanrui Xu, Xingxing He

Oncotarget · 2016 · 57 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

// Hui-Ying Xue 1, 2, * , Yong Liu 1, 2, * , Jia-Zhi Liao 1 , Ju-Sheng Lin 1 , Bin Li 2 , Wei-Gang Yuan 2 , Robert J. Lee 3 , Lei Li 2 , Chuan-Rui Xu 2 , Xing-Xing He 1 1 Institute of Liver Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2 School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 3 Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA * List of corporate first authors Correspondence to: Xing-Xing He, email: xxhe@tjh.tjmu.edu.cn Chuan-Rui Xu, email: xcr@hust.edu.cn Lei Li, email: leileilesure@163.com Keywords: microRNA, liver cancer, nanomedicine, therapy, AEG-1 Received: September 23, 2016      Accepted: November 02, 2016      Published: November 17, 2016 ABSTRACT MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver miR-375 into HCC cells by assembling miR-375 mimics on the surface of AuNPs and forming AuNP-miR-375 nanoparticles. AuNP-miR-375 exhibits high cellular uptake and preserves miR-375’s activities to suppress cellular proliferation, migration/invasion, and colony formation, and to induce apoptosis in HCC cells. Furthermore, AuNP-delivered miR-375 efficiently downregulated its target genes through RNA interference. In primary and xenograft tumor mouse models, AuNP-miR-375 showed high tumor uptake, therapeutic efficacy, and no apparent toxicity to the host mice. In conclusion, our findings indicate that AuNPs is a reliable strategy to deliver miR-375 into HCC cells and tissue, and that AuNP-miR-375 has the potential in the clinic for treatment of unresectable HCC.

References

21